| NCT ID | NCT02033811 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Klinik für Kardiologie, Pneumologie und Angiologie |
| Condition | Mitral Regurgitation |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2014-01 |
| Primary Completion | 2030-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2014-01 with a primary completion date of 2030-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Percutaneous mitral valve repair with the MitraClip® system has emerged as a therapeutic alternative to surgical valve repair (PMVR) in high risk patients. The aim of this registry is to collect prospectively and systematically clinical research data from patients undergoing PMVR with the MitraClip® system. This registry is an open-end observational study to assess the characteristics and outcomes patients with severe mitral regurgitation undergoing PMVR.
Eligibility Criteria
Inclusion Criteria: * severe mitral regurgitation * percutaneous mitral valve repair (PMVR) with the MitraClip® system Exclusion Criteria: * \< 18 years * Patients considered by the heart team to be unlikely to receive meaningful or durable clinical benefit from the procedure
Contact & Investigator
Malte Kelm, MD
📞 0049 211 81 18800
Malte Kelm, MD
PRINCIPAL INVESTIGATOR
Division of Cardiology, Pulmonary Disease and Vascular Medicine
Frequently Asked Questions
Who can join the NCT02033811 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Mitral Regurgitation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02033811 currently recruiting?
Yes, NCT02033811 is actively recruiting participants. Visit ClinicalTrials.gov or contact Klinik für Kardiologie, Pneumologie und Angiologie to inquire about joining.
Where is the NCT02033811 trial being conducted?
This trial is being conducted at Düsseldorf, Germany.
Who is sponsoring the NCT02033811 clinical trial?
NCT02033811 is sponsored by Klinik für Kardiologie, Pneumologie und Angiologie. The principal investigator is Malte Kelm, MD at Division of Cardiology, Pulmonary Disease and Vascular Medicine. The trial plans to enroll 200 participants.